Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chromosomal and gene amplification in diffuse large B-cell lymphoma

P H Rao1, J Houldsworth, K Dyomina

  • 1Cell Biology Program and the Departments of Pathology and Human Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

Blood
|June 25, 1998
PubMed
Summary

Gene amplification is frequent in diffuse large B-cell lymphomas (DLBL), affecting clinical presentation and advanced disease. This study identifies key amplified genes, including MYC and BCL2, offering insights into lymphomagenesis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comprehensive assessment of germline pathogenic variant detection in tumor-only sequencing.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Mutational Screening of BRCA1/2 Genes as a Predictive Factor for Therapeutic Response in Epithelial Ovarian Cancer: A Consensus Guide from the Spanish Society of Pathology (SEAP-IAP) and the Spanish Society of Human Genetics (AEGH).

Virchows Archiv : an international journal of pathology·2019
Same author

A phase I study of panobinostat and ruxolitinib in patients with primary myelofibrosis (PMF) and post--polycythemia vera/essential thrombocythemia myelofibrosis (post--PV/ET MF).

Leukemia research·2019
Same author

Role of minimal residual disease in the management of acute myeloid leukemia-a case-based discussion.

Annals of hematology·2018
Same author

Autologous stem-cell transplantation after second-line brentuximab vedotin in relapsed or refractory Hodgkin lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

The molecular pathogenesis of the NUP98-HOXA9 fusion protein in acute myeloid leukemia.

Leukemia·2017

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Diffuse large B-cell lymphoma (DLBL) is often characterized by chromosomal translocations affecting oncogenes.
  • Gene amplification, a known driver of tumor progression, has not been extensively studied in DLBL.

Purpose of the Study:

  • To investigate the incidence of gene amplification in DLBL.
  • To correlate gene amplification with clinical characteristics and outcomes in DLBL.

Main Methods:

  • Comparative genomic hybridization (CGH) was used to identify amplified chromosomal regions in 20 DLBL cases.
  • Quantitative Southern blotting analyzed the amplification of six candidate genes (REL, MYC, BCL2, GLI, CDK4, MDM2) in 96 DLBL cases.

Main Results:

Related Experiment Videos

  • Nine chromosomal amplification sites were identified by CGH.
  • Amplification of REL, MYC, BCL2, GLI, CDK4, and MDM2 occurred in 11-23% of DLBL cases.
  • Amplification of REL was linked to extranodal presentation, and amplification of multiple genes was associated with advanced stage disease.

Conclusions:

  • Chromosomal gene amplification is a frequent genetic event in DLBL.
  • Amplified genes like MYC and BCL2 may play significant roles in DLBL pathogenesis and progression.
  • These findings highlight the importance of gene amplification in understanding DLBL biology and clinical behavior.